Last 12 months
Inside the activity.
0 purchase rows · 42 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 17 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 06, 2026 Filed Jan 8, 2026 21:05 UTC |
Marquet MagdaDirector
|
GrantStock Option (right to buy) · Derivative | 5,500 | $0.00 Strike: $43.91 | $0.00 |
DisclosureSEC source: 0001631486-26-000001 · form4-01082026_090143.xml · derivative · entry 1 Marquet Magda · CIK 0001631486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires 2036-01-05 F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 02:04 UTC |
Lizzul Paul F.Chief Medical Officer
|
SaleCommon Stock | 4,219 | $43.26 | $182,513.94 |
DisclosureSEC source: 0001711462-26-000002 · form4-01072026_020144.xml · nonDerivative · entry 2 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,303 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 02:07 UTC |
Faga DanielDirector · President, CEO
|
SaleCommon Stock | 15,309 | $43.26 | $662,267.34 |
DisclosureSEC source: 0001673528-26-000002 · form4-01072026_020125.xml · nonDerivative · entry 2 Faga Daniel · CIK 0001673528 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 458,139 F3 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 21:03 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
SaleCommon Stock | 2,983 | $43.26 | $129,044.58 |
DisclosureSEC source: 0001239648-26-000002 · form4-01072026_020121.xml · nonDerivative · entry 2 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,251 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 02:05 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 3,363 | $43.26 | $145,483.38 |
DisclosureSEC source: 0001276840-26-000002 · form4-01072026_020152.xml · nonDerivative · entry 2 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,330 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| January 03, 2026 Filed Jan 7, 2026 02:04 UTC |
Lizzul Paul F.Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 10,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001711462-26-000002 · form4-01072026_020144.xml · derivative · entry 3 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,110 Underlying: Common Stock · 10,555 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2026 Filed Jan 7, 2026 02:04 UTC |
Lizzul Paul F.Chief Medical Officer
|
Exercise / conversionCommon Stock | 10,555 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001711462-26-000002 · form4-01072026_020144.xml · nonDerivative · entry 1 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| January 03, 2026 Filed Jan 7, 2026 02:07 UTC |
Faga DanielDirector · President, CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 34,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001673528-26-000002 · form4-01072026_020125.xml · derivative · entry 3 Faga Daniel · CIK 0001673528 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,355 Underlying: Common Stock · 34,677 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F4 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2026 Filed Jan 7, 2026 02:07 UTC |
Faga DanielDirector · President, CEO
|
Exercise / conversionCommon Stock | 34,677 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001673528-26-000002 · form4-01072026_020125.xml · nonDerivative · entry 1 Faga Daniel · CIK 0001673528 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 473,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F2 · balance_after: Reflects the acquisition of 2,305 shares acquired under the Company's ESPP. Read SEC document |
| January 03, 2026 Filed Jan 6, 2026 21:03 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001239648-26-000002 · form4-01072026_020121.xml · derivative · entry 3 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,575 Underlying: Common Stock · 7,287 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2026 Filed Jan 6, 2026 21:03 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 7,287 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001239648-26-000002 · form4-01072026_020121.xml · nonDerivative · entry 1 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| January 03, 2026 Filed Jan 7, 2026 02:05 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 8,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001276840-26-000002 · form4-01072026_020152.xml · derivative · entry 3 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,585 Underlying: Common Stock · 8,292 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2026 Filed Jan 7, 2026 02:05 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 8,292 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001276840-26-000002 · form4-01072026_020152.xml · nonDerivative · entry 1 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,693 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| December 23, 2025 Filed Dec 23, 2025 21:30 UTC |
Ware J. AnthonyDirector
|
SaleCommon Stock | 3,900 | $49.58 | $193,342.50 |
DisclosureSEC source: 0001715429-25-000003 · form4-12232025_091216.xml · nonDerivative · entry 1 Ware J. Anthony · CIK 0001715429 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,630 F1 · balance_after: In addition to the shares the Reporting Person owns reported in Table I, the Reporting Person also holds additional options to purchase up to an aggregate of 126,085 shares of common stock and 6,030 restricted stock units. Read SEC document |
| December 23, 2025 Filed Dec 23, 2025 21:29 UTC |
Schmid John P.Director
|
OtherCommon Stock | 11,068 | $51.00 | $564,468.00 |
DisclosureSEC source: 0001478916-25-000004 · form4-12232025_091225.xml · nonDerivative · entry 1 Schmid John P. · CIK 0001478916 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By ESOP Disclosed balance after: 0 F1 · kind: Shares sold under the SpeakInc. Employee Ownership Plan ("Plan") of which the Reporting Person is a trustee of the Plan. F2 · ownership.direct: The reported shares are held by the Plan of which the Reporting Person is a trustee of the Plan. The Reporting Person has less than 1% of a pecuniary interest in the Plan and disclaims beneficial ownership of these shares to the amount in excess of such Report Person's pecuniary interest. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:28 UTC |
Lizzul Paul F.Chief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $18.50 | $0.00 |
DisclosureSEC source: 0001711462-25-000003 · form4-12232025_091241.xml · derivative · entry 3 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,500 Underlying: Common Stock · 1,500 shares Expires 2030-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option is fully vested. F4 · balance_after: In addition to the remaining options to purchase 83,500 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 394,810 shares of common stock, which options vest according to their terms. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:28 UTC |
Lizzul Paul F.Chief Medical Officer
|
SaleCommon Stock | 1,500 | $50.00 | $75,000.00 |
DisclosureSEC source: 0001711462-25-000003 · form4-12232025_091241.xml · nonDerivative · entry 2 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,967 F2 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2025. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:28 UTC |
Lizzul Paul F.Chief Medical Officer
|
Exercise / conversionCommon Stock | 1,500 | $18.50 | $27,750.00 |
DisclosureSEC source: 0001711462-25-000003 · form4-12232025_091241.xml · nonDerivative · entry 1 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes the acquisition of 1,324 shares acquired under the Company's ESPP. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 16:27 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $14.02 | $0.00 |
DisclosureSEC source: 0001239648-25-000006 · form4-12232025_091230.xml · derivative · entry 3 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,000 Underlying: Common Stock · 10,000 shares Expires 2029-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option is fully vested. F3 · balance_after: In addition to the options to purchase a total of 43,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 414,810 shares of common stock, which options vest according to their terms. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 16:27 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
SaleCommon Stock | 10,000 | $51.00 | $510,000.00 |
DisclosureSEC source: 0001239648-25-000006 · form4-12232025_091230.xml · nonDerivative · entry 2 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,947 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 16:27 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 10,000 | $14.02 | $140,200.00 |
DisclosureSEC source: 0001239648-25-000006 · form4-12232025_091230.xml · nonDerivative · entry 1 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:28 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $20.16 | $0.00 |
DisclosureSEC source: 0001276840-25-000004 · form4-12232025_091206.xml · derivative · entry 3 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,600 Underlying: Common Stock · 10,000 shares Expires 2030-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option is fully vested. F3 · balance_after: In addition to the remaining options to purchase 60,600 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 339,440 shares of common stock, which options vest according to their terms. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:28 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 10,000 | $50.00 | $500,000.00 |
DisclosureSEC source: 0001276840-25-000004 · form4-12232025_091206.xml · nonDerivative · entry 2 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,401 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 11, 2025. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:28 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 10,000 | $20.16 | $201,600.00 |
DisclosureSEC source: 0001276840-25-000004 · form4-12232025_091206.xml · nonDerivative · entry 1 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2025 Filed Dec 18, 2025 16:14 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
SaleCommon Stock | 141 | $46.99 | $6,625.59 |
DisclosureSEC source: 0001239648-25-000005 · form4-12182025_091200.xml · nonDerivative · entry 7 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,947 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 16:14 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $14.02 | $0.00 |
DisclosureSEC source: 0001239648-25-000005 · form4-12182025_091200.xml · derivative · entry 10 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,000 Underlying: Common Stock · 10,000 shares Expires 2029-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option is fully vested. F5 · balance_after: In addition to the options to purchase a total of 53,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 414,810 shares of common stock, which options vest according to their terms. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 16:14 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
SaleCommon Stock | 10,000 | $46.00 | $460,000.00 |
DisclosureSEC source: 0001239648-25-000005 · form4-12182025_091200.xml · nonDerivative · entry 6 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,088 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 16:14 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 10,000 | $14.02 | $140,200.00 |
DisclosureSEC source: 0001239648-25-000005 · form4-12182025_091200.xml · nonDerivative · entry 5 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 16:14 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $20.16 | $0.00 |
DisclosureSEC source: 0001239648-25-000005 · form4-12182025_091200.xml · derivative · entry 9 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2030-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 16:14 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $14.02 | $0.00 |
DisclosureSEC source: 0001239648-25-000005 · form4-12182025_091200.xml · derivative · entry 8 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,000 Underlying: Common Stock · 5,000 shares Expires 2029-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 16:14 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
SaleCommon Stock | 4,195 | $45.24 | $189,768.80 |
DisclosureSEC source: 0001239648-25-000005 · form4-12182025_091200.xml · nonDerivative · entry 4 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,088 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.13 to $45.34 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 16:14 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
SaleCommon Stock | 8,305 | $44.68 | $371,030.86 |
DisclosureSEC source: 0001239648-25-000005 · form4-12182025_091200.xml · nonDerivative · entry 3 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,283 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.12 to $45.11 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 16:14 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 7,500 | $20.16 | $151,200.00 |
DisclosureSEC source: 0001239648-25-000005 · form4-12182025_091200.xml · nonDerivative · entry 2 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,588 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 16:14 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 5,000 | $14.02 | $70,100.00 |
DisclosureSEC source: 0001239648-25-000005 · form4-12182025_091200.xml · nonDerivative · entry 1 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:13 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $20.16 | $0.00 |
DisclosureSEC source: 0001276840-25-000003 · form4-12182025_091222.xml · derivative · entry 4 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,600 Underlying: Common Stock · 10,000 shares Expires 2030-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option is fully vested. F6 · balance_after: In addition to the remaining options to purchase 70,600 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 339,440 shares of common stock, which options vest according to their terms. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:13 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 6,360 | $45.21 | $287,511.43 |
DisclosureSEC source: 0001276840-25-000003 · form4-12182025_091222.xml · nonDerivative · entry 3 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,401 F2 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 11, 2025. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.065 to $45.32 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:13 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 9,365 | $44.62 | $417,821.35 |
DisclosureSEC source: 0001276840-25-000003 · form4-12182025_091222.xml · nonDerivative · entry 2 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,761 F2 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 11, 2025. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.07 to $45.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:13 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 10,000 | $20.16 | $201,600.00 |
DisclosureSEC source: 0001276840-25-000003 · form4-12182025_091222.xml · nonDerivative · entry 1 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Reflects the acquisition of 1,324 shares acquired under the Company's ESPP. Read SEC document |
| September 30, 2025 Filed Oct 1, 2025 16:00 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $14.02 | $0.00 |
DisclosureSEC source: 0001239648-25-000004 · form4-10012025_081017.xml · derivative · entry 3 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,000 Underlying: Common Stock · 5,000 shares Expires 2029-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vested and is exercisable as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. F4 · balance_after: In addition to the remaining options to purchase 68,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 422,310 shares of common stock, which options vest according to their terms. Read SEC document |
| September 30, 2025 Filed Oct 1, 2025 16:00 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
SaleCommon Stock | 8,240 | $29.00 | $238,960.00 |
DisclosureSEC source: 0001239648-25-000004 · form4-10012025_081017.xml · nonDerivative · entry 2 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,088 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025. Read SEC document |
| September 30, 2025 Filed Oct 1, 2025 16:00 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 5,000 | $14.02 | $70,100.00 |
DisclosureSEC source: 0001239648-25-000004 · form4-10012025_081017.xml · nonDerivative · entry 1 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,328 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes the acquisition of 1,325 shares acquired under the Company's ESPP. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 20:02 UTC |
Orwin John ADirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001477384-25-000004 · form4-09172025_080918.xml · derivative · entry 2 Orwin John A · CIK 0001477384 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,300 Underlying: Common Stock · 1,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: The RSUs shall vest as to 1/3 of the total shares on September 15, 2024, and thereafter vests as to 1/3 of the total RSUs on September 15, 2025; and as to 1/3 of the total RSUs on September 15, 2026, subject to the provision of services to the Company on each vesting date. F2 · derivative.expiration_date: The RSUs shall vest as to 1/3 of the total shares on September 15, 2024, and thereafter vests as to 1/3 of the total RSUs on September 15, 2025; and as to 1/3 of the total RSUs on September 15, 2026, subject to the provision of services to the Company on each vesting date. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 20:02 UTC |
Orwin John ADirector
|
Exercise / conversionCommon Stock | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001477384-25-000004 · form4-09172025_080918.xml · nonDerivative · entry 1 Orwin John A · CIK 0001477384 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:02 UTC |
RENTON HOLLINGSDirector
|
Exercise / conversionCommon Stock · Derivative | 10,231 | $0.00 Strike: $6.93 | $0.00 |
DisclosureSEC source: 0001415889-25-021486 · form4-08122025_080842.xml · derivative · entry 4 RENTON HOLLINGS · CIK 0001187333 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,231 shares Expires 2025-08-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option grant was issued on August 14, 2015, is fully vested and exercisable until its expiration date of August 13, 2025. F5 · balance_after: In addition to the remaining options to purchase 10,231 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 101,820 shares of common stock, which options vest according to their terms. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:02 UTC |
RENTON HOLLINGSDirector
|
SaleCommon Stock | 7,121 | $19.70 | $140,255.22 |
DisclosureSEC source: 0001415889-25-021486 · form4-08122025_080842.xml · nonDerivative · entry 3 RENTON HOLLINGS · CIK 0001187333 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,965 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Mr. Renton holds various stock options that are expiring in 2025 and wished to put the plan in place to facilitate the orderly exercise of such options, including the options exercised and sold under this Form 4, which have an expiration date of August 13, 2025. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.48 to $20.46 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:02 UTC |
RENTON HOLLINGSDirector
|
SaleCommon Stock | 3,110 | $19.44 | $60,458.40 |
DisclosureSEC source: 0001415889-25-021486 · form4-08122025_080842.xml · nonDerivative · entry 2 RENTON HOLLINGS · CIK 0001187333 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,086 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Mr. Renton holds various stock options that are expiring in 2025 and wished to put the plan in place to facilitate the orderly exercise of such options, including the options exercised and sold under this Form 4, which have an expiration date of August 13, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.375 to $19.46 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:02 UTC |
RENTON HOLLINGSDirector
|
Exercise / conversionCommon Stock | 10,231 | $6.93 | $70,900.83 |
DisclosureSEC source: 0001415889-25-021486 · form4-08122025_080842.xml · nonDerivative · entry 1 RENTON HOLLINGS · CIK 0001187333 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 17:34 UTC |
RENTON HOLLINGSDirector
|
Exercise / conversionCommon Stock · Derivative | 20,925 | $0.00 Strike: $6.93 | $0.00 |
DisclosureSEC source: 0001415889-25-019242 · form4-07032025_050730.xml · derivative · entry 4 RENTON HOLLINGS · CIK 0001187333 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,925 shares Expires 2025-07-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option grant was issued on July 6, 2015, is fully vested and exercisable until its expiration date of July 5, 2025. F5 · balance_after: In addition to the remaining options to purchase 20,925 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 112,051 shares of common stock, which options vest according to their terms. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 17:34 UTC |
RENTON HOLLINGSDirector
|
SaleCommon Stock | 13,675 | $23.82 | $325,782.26 |
DisclosureSEC source: 0001415889-25-019242 · form4-07032025_050730.xml · nonDerivative · entry 3 RENTON HOLLINGS · CIK 0001187333 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,965 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Mr. Renton holds various stock options that are expiring in 2025 and wished to put the plan in place to facilitate the orderly exercise of such options, including the options exercised and sold under this Form 4, which have an expiration date of July 5, 2025. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.56 to $24.015 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 17:34 UTC |
RENTON HOLLINGSDirector
|
SaleCommon Stock | 7,250 | $23.09 | $167,408.30 |
DisclosureSEC source: 0001415889-25-019242 · form4-07032025_050730.xml · nonDerivative · entry 2 RENTON HOLLINGS · CIK 0001187333 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,640 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Mr. Renton holds various stock options that are expiring in 2025 and wished to put the plan in place to facilitate the orderly exercise of such options, including the options exercised and sold under this Form 4, which have an expiration date of July 5, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.425 to $23.395 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.